Lv4
580 积分 2026-03-12 加入
Emerging incretin- and multi-agonist-based treatments – the continued refinement and continuous expansion of a potent therapeutic armamentarium for cardio-kidney-liver-metabolic diseases and beyond
4天前
已完结
Incorporating Selenium into Heterocycles and Natural Products─From Chemical Properties to Pharmacological Activities
12天前
已完结
GAP positions catalytic H-Ras residue Q61 for GTP hydrolysis in molecular dynamics simulations, complicating chemical rescue of Ras deactivation
16天前
已完结
Application of Bioisosteres in the Design and Discovery of FDA-Approved Drugs and Advanced Clinical Candidates
22天前
已完结
Discovery of BI-2493, a Pan-KRAS Inhibitor Showing In Vivo Efficacy
1个月前
已完结
Discovery of Elironrasib (RMC-6291), a Potent and Orally Bioavailable, RAS(ON) G12C-Selective, Covalent Tricomplex Inhibitor for the Treatment of Patients with RAS G12C-Addicted Cancers
1个月前
已完结
Construction of the 2-Amino-1,3-selenazole Skeleton via PhICl2/KSeCN-Mediated Selenocyanation/Cyclization
1个月前
已完结
Synthesis and biological evaluation of selenogefitinib for reducing bleomycin-induced pulmonary fibrosis
1个月前
已完结
Selenization of Small Molecule Drugs: A New Player on the Board
1个月前
已完结
N‐Confused Phlorin‐Prodigiosin Chimera: meso‐Aryl Oxidation and π‐Extension Triggered by Peripheral Coordination
2个月前
已完结
皖公网安备34019202002308
